Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. (Q46694616)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group. |
scientific article |
Statements
Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group (English)
Aron Goldhirsch
Meredith M Regan
Piergiovanni Grigolato
Rastko Golouh
Tiziana Perin
Robert W Brown
Anikó Kovács
Komala Pillay
Christian Ohlschlegel
Stephen Braye
Tiziana Rusca
Richard D Gelber
Monica Castiglione-Gertsch
Karen N Price
Barry A Gusterson
Alan S Coates